CMG Group commences C$20M share buyback at premium
Computer Modelling Group Ltd. has commenced a C$20 million share buyback at a 7-20% premium, expiring September 21, 2026. The move follows Q1FY27 results showing a 6% revenue decline and 60% net income drop, supported by an undrawn $100 million credit facility. The bid aims to return capital while preserving flexibility for strategic acquisitions.
*this image is generated using AI for illustrative purposes only.
Computer Modelling Group Ltd. ("CMG") has formally commenced its previously announced substantial issuer bid (SIB) to repurchase up to C$20 million of its outstanding common shares. The offer, which began on August 14, 2026, will expire on September 21, 2026, unless extended or withdrawn. This capital return program is structured as a modified Dutch auction, allowing shareholders to tender via auction, purchase price, or proportionate methods. The SIB offers a significant upside, with a price range of C$4.00 to C$4.50 per share, representing a 7% to 20% premium over the August 11, 2026 closing price.
The Board of Directors believes the repurchase is in the best interests of shareholders, citing that shares are trading at a meaningful discount to intrinsic value. The company views the offer as accretive to remaining shareholders by increasing their proportional ownership at a price below long-term value assessments. National Bank Financial acts as financial advisor and dealer manager, while Olympia Trust Company serves as depositary. The final purchase price will be determined by the lowest price that allows the company to purchase all validly deposited auction and purchase price tenders within the available funds.
Financial Context and Liquidity Position
The buyback announcement coincides with CMG's Q1FY27 financial report, which showed total revenue declining 6% to $27.8 million. Recurring revenue dropped 3% to $20.3 million, while professional services revenue fell 16% to $7.1 million due to the absence of prior-year CoFlow-related development funding. Adjusted EBITDA decreased 10% to $6.4 million, with margins contracting to 23%. Despite these headwinds, the company approved a cash dividend of $0.01 per common share, payable on September 15, 2026, to shareholders of record on September 4, 2026.
| Metric | Q1FY27 ($ thousands) | Q1FY26 ($ thousands) | % Change |
|---|---|---|---|
| Total Revenue | 27,845 | 29,633 | (6)% |
| Recurring Revenue | 20,289 | 20,852 | (3)% |
| Professional Services | 7,059 | 8,403 | (16)% |
| Net Income | 1,326 | 3,309 | (60)% |
| Adjusted EBITDA | 6,389 | 7,074 | (10)% |
Strategic Rationale and Capital Allocation
The decision to launch the SIB is underpinned by confidence in the durability of the company’s recurring revenue base and free cash flow generation. CMG highlights its strong liquidity position, including access to an essentially undrawn $100 million credit facility, which enables the repurchases while maintaining the capacity to fund organic growth initiatives. The offer is intended to complement, not replace, the company’s long-term capital allocation strategy, which continues to prioritize disciplined merger and acquisition alongside organic investment.
Having completed its prior normal course issuer bid and being unable to renew it until November 2026, the SIB provides a timely mechanism to return capital now. The acquisition pipeline remains active, but the company will continue to be selective on price and expected returns. Importantly, none of the company’s directors, officers, or persons beneficially owning more than 10% of voting rights intend to tender their shares to the offer.
What the Numbers Show
The launch of a C$20 million buyback amid a 60% drop in net income highlights a strategic divergence between operational performance and capital allocation. While organic revenue contracted by 16%, acquisitions contributed 10% growth, masking underlying weakness. The SIB offers non-participating shareholders a proportionate increase in equity interest, potentially boosting earnings per share if fully utilized. However, the reliance on external growth to offset organic declines suggests that integration risks remain a key factor for investors evaluating the long-term value of this capital return program.
How might the 60% decline in net income and contracting EBITDA margins impact CMG's ability to sustain this capital return strategy if organic revenue continues to underperform?
Given that insiders are not tendering shares, what specific catalysts does management anticipate will drive the stock price above the C$4.50 auction ceiling before the offer expires?
Will the utilization of the SIB constrain CMG's capacity to execute its stated M&A pipeline, particularly if attractive acquisition targets emerge before the November 2026 NCIB renewal?
17
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
